- Angela Devine is a health economist with Menzies School of Health Research. She holds joint honorary positions with the University of Melbourne and the University of Oxford. Her current research is focused on the burden of disease and cost-effectiveness of options for the management of vivax malaria. In particular, she investigates options for improving the safe and effective deployment of primaquine in a variety of transmission and geographical settings in order to optimize a global strategy for the radical cure of vivax malaria. Her previous work research has addressed a variety of topics, including the impact of early antiretroviral therapy for individuals with HIV and hepatitis B co-infections, strategies for cervical cancer screening in HIV clinics in Africa and modelling the long-term impact of an identification and referral programme for intimate partner violence.